Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer: a Multicenter, Single Arm Prospective Study
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Adebrelimab (Primary) ; Capecitabine; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 16 Jan 2025 New trial record